CIK 0001527352
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Nexalin Technology, Inc.
Sign in to watch- Ticker
- NXL
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 275566468
- Phone
- +1 832-260-0222
- Business address
- 1776 YORKTOWN, SUITE 550, HOUSTON, TX, 77056
- 4/A Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 4/A Open-market buy President/CEO bought 25,000 shares at $4.15 ($103,750)
- 4/A Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 3/A Insider 3/A
- 3/A Insider 3/A
- 4 Open-market buy Ms. Elson serves as CFO bought 9,500 shares at $1.12 ($10,640)
- 4/A Open-market buy President/CEO bought 25,000 shares at $4.15 ($103,750)
- 4 Open-market buy Ms. Elson serves as CFO bought 36,000 shares at $4.15 ($149,400)
- 4 Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 4 Open-market buy Director bought 2,500 shares at $4.15 ($10,375)
- 4 Open-market buy Chief Medical Officer bought 2,500 shares at $4.15 ($10,375)
- 4 Open-market buy President/CEO bought 2,500 shares at $4.15 ($10,375)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 3 of 3 · 58 filings